GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Accumulated Depreciation

Alto Neuroscience (Alto Neuroscience) Accumulated Depreciation : $-0.78 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Alto Neuroscience's quarterly accumulated depreciation declined from Sep. 2023 ($-0.73 Mil) to Dec. 2023 ($-0.68 Mil) but then increased from Dec. 2023 ($-0.68 Mil) to Mar. 2024 ($-0.78 Mil).

Alto Neuroscience's annual accumulated depreciation increased from Dec. 2021 ($-0.24 Mil) to Dec. 2022 ($-0.58 Mil) and increased from Dec. 2022 ($-0.58 Mil) to Dec. 2023 ($-0.68 Mil).

Alto Neuroscience Accumulated Depreciation Historical Data

The historical data trend for Alto Neuroscience's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Accumulated Depreciation Chart

Alto Neuroscience Annual Data
Trend Dec21 Dec22 Dec23
Accumulated Depreciation
-0.24 -0.58 -0.68

Alto Neuroscience Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Accumulated Depreciation Get a 7-Day Free Trial -0.58 - -0.73 -0.68 -0.78

Alto Neuroscience Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Alto Neuroscience Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Alto Neuroscience's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Accumulated Depreciation
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024